Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity

Figure 2 Diagnostic probability of leucine-rich α-2-glycoprotein, C-reactive protein, and fecal calprotectin for detecting active endoscopic disease in patients with ulcerative colitis and Crohn’s disease with low C-reactive protein levels. A: In patients with ulcerative colitis with low C-reactive protein levels; B: In patients with Crohn’s disease with low C-reactive protein levels. UC: Ulcerative colitis; CRP: C-reactive protein; FC: Fecal calprotectin; LRG: Leucine-rich α-2-glycoprotein; AUROC: Area under the receiver operating characteristic curve; CD: Crohn’s disease.